Aklief Cream is a prescription-strength topical retinoid formulated with Trifarotene 0.005%, designed to treat acne vulgaris on the face, chest, shoulders, and back. As the first new retinoid molecule approved in over 20 years, Aklief selectively targets the retinoic acid receptor-gamma (RAR-γ), the most prevalent receptor in the skin, offering effective acne treatment with potentially fewer side effects compared to traditional retinoids.